Abstract
The β2-adrenergic receptor has been shown to be involved in neuroendocrine differentiation and to contribute to the development of aggressive prostate cancer. In this study we have investigated whether miR-196a plays a role in the regulation of the β2-adrenergic receptor in the LNCaP prostate cancer cell line. Our results show that the expression of miR-196a is elevated in LNCaP prostate cancer cells with reduced levels of β2-adrenergic receptor after stably transfection with three different shRNAs. Furthermore, treatment with β-blockers showed that this upregulation is strictly related to the low levels of β2-adrenergic receptor and not to the inhibition of the receptor signaling activity. Finally, we found that the reduced ability of LNCaP cells with low levels of β2-adrenergic receptor to initiate neuroendocrine differentiation under androgen depletion conditions is mediated by miR-196a. In conclusion, this study provides the rational for a role of miR-196a in the β2-adrenergic receptor mediated neuroendocrine differentiation of LNCaP prostate cancer cells.
Funder
Helse Sør-Øst RHF
Norges Forskningsråd
Kreftforeningen
Universitetet i Oslo
Oslo University Hospital
Fondazione Umberto Veronesi
Publisher
Public Library of Science (PLoS)
Reference35 articles.
1. Cancer statistics, 2020;RL Siegel;CA Cancer J Clin,2020
2. Role of Androgen Receptor in Prostate Cancer: A Review;K Fujita;World J Mens Health,2019
3. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer;J Morote;Eur Urol,2018
4. Androgen Signaling in Prostate Cancer;C Dai;Cold Spring Harb Perspect Med,2017
5. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer;PA Watson;Nat Rev Cancer,2015
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献